Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

Gastrointestinal Disease ELISA Kits for Gastrointestinal Disorders

The use of electrical stimulation of nerves or brain centres as a therapeutic tool is being trialled in an increasing range of human diseases, including Parkinson disease, arthritis, depressive illness, schizophrenia, pain and bladder dysfunction. This treatment approach is referred to variously as, simply, neuromodulation, or as bioelectric neuromodulation or electroceuticals. The possibility that bioelectric neuromodulation could be used to relieve gastrointestinal-related disorders has created considerable interest in the clinical community, and stimulation at a range of sites of the gastrointestinal tract for several different conditions has been investigated.

In most cases, outcomes have been variable and mechanisms of action remain unclear, leaving important therapeutic questions unanswered, for example, optimal stimulus parameters, which have been reviewed elsewhere. Possible target populations and strategies for neuromodulation therapies applied to the gut have also been reviewed. A clear understanding of the biology of the innervation of the gastrointestinal tract is therefore needed to maximize the effectiveness and minimize the adverse effects of bioelectrical neuromodulation therapy.

Fig. 1 Sites of bioelectric neuromodulation to change gastrointestinal functions.Fig. 1 Sites of bioelectric neuromodulation to change gastrointestinal functions. (Payne SC, et al., 2019)

Nerve stimulation for IBD

Crohn's disease and ulcerative colitis, collectively termed IBD, are the most common immune-mediated disorders of the gastrointestinal tract. In a substantial proportion of these patients the disease recurs despite ongoing biological or pharmacological preventive treatment. Thus, new therapies that are more effective and have fewer adverse effects than current treatments are needed.

VNS for IBD. Experimental and clinical trials of vagal nerve stimulation (VNS) to alleviate IBD have had variable outcomes. VNS (3 hours per day) applied to awake rats with TNBS-induced colitis effectively reduced weight loss, colonic histological score and molecular expression of pro-inflammatory cytokines that were measured in the intestine adjacent to the inflammatory lesion.

SNS for IBD. In a single patient with proctitis, sacral nerve stimulation (SNS) to relieve faecal incontinence improved the state of the rectal mucosa.

Neuromodulation for obesity

Obesity treatment is among the most developed applications for bioelectric neuromodulation. Neuromodulation devices for the treatment of obesity have been used to change activity in the vagus nerve directly or have been applied to the gastric surface.

Vagal nerve blocking for obesity. Cutting the abdominal vagus causes a decrease in food intake in individuals with healthy weight and those with obesity, and in laboratory rats.

VNS for obesity. VNS might have an additional benefit in individuals with obesity, as obesity results in chronic low-grade inflammation that is involved in the pathogenesis of obesity-related insulin resistance and type 2 diabetes mellitus.

GES for obesity. Gastric electrical stimulation (GES) is a term used to describe electrical stimulation to the surface of the stomach or to vagal branches on the gastric surface.

Nerve stimulation for colorectal dysfunction

Faecal continence and defecation are under voluntary control in humans, who can, in healthy conditions, decide when to retain or release bowel contents. However, the control is impaired in patients with disorders, including Parkinson disease, multiple sclerosis, childhood constipation and idiopathic conditions, that are associated with diarrhoea, faecal soiling or constipation. In the search for better treatments for colorectal disorders, a range of bioelectric neuromodulation methods have been investigated.

SNS for faecal incontinence. Pelvic nerve stimulation, generally referred to as sacral nerve stimulation (SNS) because the autonomic outflows (pelvic nerves) from the lower spinal cord run initially in the sacral nerves, has been used for >20 years to treat faecal incontinence.

SARS for constipation. Sacral anterior root stimulation (SARS) is a modification of SNS for treating constipation. In a study in >200 patients with constipation as a consequence of SCI (median age 49 years), SARS increased the frequency of defecation, reduced bowel emptying times and reduced the use of oral laxatives or suppositories and digital evacuation compared with patients pre-implant.

TIENS for constipation. Transcutaneous interferential electrical nerve stimulation (TIENS) is a method in which oscillating currents, generally 1-4 kHz sinusoidal currents, are passed between pairs of surface electrodes.

Reference

  1. Payne SC, Furness JB, Stebbing MJ. Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms. Nat Rev Gastroenterol Hepatol. 2019; 16 (2):89-105.

ELISA Kits

TargetCat. No.Product NameSizeSpecies ReactivityApplicationDetection SampleInquiry
ADVDEIAFY103Adenovirus Hexon Antigen ELISA Kit2×96TN/AQualitativeFecesInquiry
ADVDEIASL108Mouse Adenovirus FL ELISA Kit96TMouseQualitiveSerumInquiry
ADVDEIASL109Mouse Adenovirus K87 ELISA Kit96TMouseQualitiveSerumInquiry
ADVDEIA309Human Anti-Adenovirus IgG ELISA Kit96THumanQuantitativeSerum, plasmaInquiry
ADVDEIA310Adenovirus IgA ELISA Kit96THumanQuantitativeserum, plasmaInquiry
ADVDEIA311Adenovirus IgM ELISA Kit96THumanQuantitativeserum, plasmaInquiry
ADVDEIA1767Adenovirus IgM ELISA Kit96THumanSemi-Quantitative, QualitativeserumInquiry
ADVDEIA2435Adenovirus (Fecal) ELISA Kit96TN/AQualitativeStoolInquiry
ADVDEIA2382Adenovirus IgG ELISA Kit96THumanQualitativeHuman serum or plasma (citrate, heparin)Inquiry
ADVDEIA2094Mouse Adenovirus-FLandK87 EcoELISA Kit96TMouseQualitativeserumInquiry
ADVDEIA1383Human Adenovirus IgA (ADV-IgA) ELISA Kit96THumanQualitativeSerum or plasmaInquiry
ADVDEIA1383GHuman Adenovirus IgG ELISA Kit96THumanQualitativeSerum, plasmaInquiry
C. JejuniDEIA-XY89Campylobacter jejuni IgA ELISA Kit96THumanQuantitativeserum, EDTA plasma, heparin plasma, citrate plasmaInquiry
C. JejuniDEIA-XY90Campylobacter jejuni IgG ELISA Kit96THumanQualitativeSerum or plasma (EDTA, citrate, heparin).Inquiry
C. JejuniDEIA-XY91Campylobacter jejuni IgM ELISA Kit96THumanQuantitativeserum, EDTA plasma, heparin plasma, citrate plasmaInquiry
CalprotectinDEIA2176FMouse/Rat S100A8/S100A9 ELISA Kit96TMouse, RatQuantitativestool, serum, plasma, urine, tissue extract, cell culture supernatantInquiry
CalprotectinDEIABL65Human S100A8/S100A9 Heterodimer ELISA development kit96T×5HumanQuantitativeCell culture supernate, serum, plasma, saliva, human milk, urine, and fecal samplesInquiry
CalprotectinDEIABL64Mouse S100A8/S100A9 Heterodimer ELISA development kit96T×5MouseQuantitativeCell culture supernate, serum, and plasma samplesInquiry
CalprotectinDEIA-XY2170Mouse S100A9/Calprotectin ELISA kit96TMouse, Goat, Pig, RabbitQuantitativeserum, plasmaInquiry
CalprotectinDEIA52610PYChicken Calprotectin ELISA Kit96TChickenQuantitativeSerum, plasma, tissue homogenates and other biological fluids.Inquiry
CalprotectinDEIA042JCalprotectin (MRP 8/14) ELISA Kit96THumanQuantitativestoolInquiry
CalprotectinDEIA043JCalprotectin (MRP 8/14) ELISA Kit96THumanQuantitativeurineInquiry
CalprotectinDEIA2223Human Calprotectin Stool ELISA Kit96THumanQuantitativestoolInquiry
CalprotectinDEIA2166Human Calprotectin ELISA96THumanQuantitativeStool, Serum, Urine, Sputum, PlasmaInquiry
CalprotectinDAEF-012Pig calprotectin (CALP) ELISA Kit96T QuantitiveSerum, Plasma and Tissue HomogenatesInquiry
CalprotectinDEIA2166RHuman S100A8/S100A9 Heterodimer ELISA Kit96THumanQuantitativeCell culture supernates, tissue lysates, serum, plasma, saliva, urine, human milk, fecal extractInquiry
CryptoDEIA2436Cryptosporidium (Fecal) ELISA Kit96THumanQualitativefecesInquiry
H. pyloriDEIA341Human Helicobacter pylori IgG ELISA kit96THumanQuantitativeserum, plasmaInquiry
H. pyloriDEIA342Human Helicobacter pylori IgA ELISA kit96THumanQuantitativeserum, plasmaInquiry
H. pyloriDEIA343Human Helicobacter pylori IgM ELISA kit96THumanQuantitativeserum, plasmaInquiry
H. pyloriDEIA-BJ763Human Helicobacter pylori-Hsp60 ELISA kit96THumanQuantitativeSerum, plasma, cell culture supernatants, body fluid and tissue homogenateInquiry
H. pylori CagADEIA1900CagA IgG ELISA Kit96THumanQualitativeserum, plasmaInquiry
H. pyloriDEIA1951H. Pylori Ag Stool Extraction Kit50T   Inquiry
H. pyloriDEIABL338Helicobacter pylori-Antigen ELISA Kit96TN/AQuantitative, QualitativefecesInquiry
H. pyloriDEIA1865H. Pylori Antibody IgA ELISA Kit96THumanQualitativeserum, plasma, stoolInquiry
H. pyloriDEIA1780Helicobacter pylori IgA ELISA Kit96THumanQualitativeserumInquiry
H. PyloriDEIACL36CDSimple™ Anti-H. Pylori IgA Chemiluminescent ELISA Kit96THumanQuantitativeSerumInquiry
H. PyloriDEIACL37CDSimple™ Anti-H. Pylori IgG Chemiluminescent ELISA Kit96THumanQuantitativeSerumInquiry
H. PyloriDEIACL38CDSimple™ Anti-H. Pylori IgM Chemiluminescent ELISA Kit96THumanQuantitativeSerumInquiry

Rapid Test Kits

TargetCat. No.Product NameSizeSpecies ReactivityApplicationDetection SampleInquiry
CalprotectinDTS599Calprotectin Rapid Test20THumanQualitativeFaecesInquiry
Inquiry Basket